Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Interactome networks and human disease.

Vidal M, Cusick ME, Barabási AL.

Cell. 2011 Mar 18;144(6):986-98. doi: 10.1016/j.cell.2011.02.016. Review.

2.

Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction.

Inuzuka H, Fukushima H, Shaik S, Wei W.

Oncotarget. 2010 Nov;1(7):685-90. Review.

3.

A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs.

Murai R, Yoshida Y, Muraguchi T, Nishimoto E, Morioka Y, Kitayama H, Kondoh S, Kawazoe Y, Hiraoka M, Uesugi M, Noda M.

Oncotarget. 2010 Aug;1(4):252-64.

4.

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.

Tefferi A, Vainchenker W.

J Clin Oncol. 2011 Feb 10;29(5):573-82. doi: 10.1200/JCO.2010.29.8711. Epub 2011 Jan 10. Review.

PMID:
21220604
5.

A network-based biomarker approach for molecular investigation and diagnosis of lung cancer.

Wang YC, Chen BS.

BMC Med Genomics. 2011 Jan 6;4:2. doi: 10.1186/1755-8794-4-2.

6.

Network medicine: a network-based approach to human disease.

Barabási AL, Gulbahce N, Loscalzo J.

Nat Rev Genet. 2011 Jan;12(1):56-68. doi: 10.1038/nrg2918. Review.

7.

An integrated approach to uncover drivers of cancer.

Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton HC, Pochanard P, Mozes E, Garraway LA, Pe'er D.

Cell. 2010 Dec 10;143(6):1005-17. doi: 10.1016/j.cell.2010.11.013. Epub 2010 Dec 2.

8.

Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.

Akakura S, Nochajski P, Gao L, Sotomayor P, Matsui S, Gelman IH.

Cell Cycle. 2010 Dec 1;9(23):4656-65. Epub 2010 Dec 1.

9.

Pathway Commons, a web resource for biological pathway data.

Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, Schultz N, Bader GD, Sander C.

Nucleic Acids Res. 2011 Jan;39(Database issue):D685-90. doi: 10.1093/nar/gkq1039. Epub 2010 Nov 10.

10.

Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis.

Kocarnik JD, Hutter CM, Slattery ML, Berndt SI, Hsu L, Duggan DJ, Muehling J, Caan BJ, Beresford SA, Rajkovic A, Sarto GE, Marshall JR, Hammad N, Wallace RB, Makar KW, Prentice RL, Potter JD, Hayes RB, Peters U.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3131-9. doi: 10.1158/1055-9965.EPI-10-0878. Epub 2010 Oct 26.

11.

miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.

Noonan EJ, Place RF, Basak S, Pookot D, Li LC.

Oncotarget. 2010 Sep;1(5):349-58.

12.

Is miR-29 an oncogene or tumor suppressor in CLL?

Pekarsky Y, Croce CM.

Oncotarget. 2010 Jul;1(3):224-7.

13.

An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.

Lu X, Zhang K, Van Sant C, Coon J, Semizarov D.

BMC Med Genomics. 2010 Jun 22;3:23. doi: 10.1186/1755-8794-3-23.

14.

Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.

Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, Li J, Hasina R, Cheng C, Lingen MW, Gerstein MB, Weichselbaum RR, Xing HR, Lussier YA.

PLoS Comput Biol. 2010 Apr 1;6(4):e1000730. doi: 10.1371/journal.pcbi.1000730.

15.

The landscape of somatic copy-number alteration across human cancers.

Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M.

Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.

16.

Disease-aging network reveals significant roles of aging genes in connecting genetic diseases.

Wang J, Zhang S, Wang Y, Chen L, Zhang XS.

PLoS Comput Biol. 2009 Sep;5(9):e1000521. doi: 10.1371/journal.pcbi.1000521. Epub 2009 Sep 25.

17.

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.

Gunnarsson R, Isaksson A, Mansouri M, Göransson H, Jansson M, Cahill N, Rasmussen M, Staaf J, Lundin J, Norin S, Buhl AM, Smedby KE, Hjalgrim H, Karlsson K, Jurlander J, Juliusson G, Rosenquist R.

Leukemia. 2010 Jan;24(1):211-5. doi: 10.1038/leu.2009.187. Epub 2009 Sep 10. No abstract available.

PMID:
19741724
18.

The multiple levels of regulation by p53 ubiquitination.

Lee JT, Gu W.

Cell Death Differ. 2010 Jan;17(1):86-92. doi: 10.1038/cdd.2009.77. Review.

19.

Degradation of activated protein kinases by ubiquitination.

Lu Z, Hunter T.

Annu Rev Biochem. 2009;78:435-75. doi: 10.1146/annurev.biochem.013008.092711. Review.

20.

Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.

Gunduz E, Gunduz M, Ali MA, Beder L, Tamamura R, Katase N, Tominaga S, Yamanaka N, Shimizu K, Nagatsuka H.

Cancer Invest. 2009 Jul;27(6):661-8. doi: 10.1080/07357900802563010.

PMID:
19488910

Supplemental Content

Support Center